IL6 and breast carcinoma: The activation of the IL-6 and IL-11-dependent signaling cascade leads to the phosphorylation of STAT3 to transcriptionally activate genes and pathways that promote breast cancer proliferation, suppress apoptosis, allow for immune evasion leading to metastatic growth, and attain chemoresistance.